Prolonged glucocorticoid therapy is considered to be the most common cause of secondary
adrenal insufficiency. Despite this, its true incidence remains unknown and the risk of acute …

Prolonged glucocorticoid therapy is considered to be the most common cause of secondary
adrenal insufficiency. Despite this, its true incidence remains unknown and the risk of acute …

Adrenal insufficiency (AI) induced by glucocorticoids was first described more than 50 years
ago in patients undergoing surgical stress. Although considered the most frequent cause of …

Adrenal insufficiency (AI) is a rare disease with an estimated prevalence of less than 300 per
million [1]. AI can either be the result of destruction of the adrenal glands (primary AI), or of …

Adrenal insufficiency (AI) is a rare disease caused by destruction of the adrenal glands or
dysfunction of the pituitary gland or the hypothalamus. Treatment usually requires lifelong …

Background Biochemical adrenal insufficiency induced by glucocorticoid treatment is
prevalent, but data on the clinical implications are sparse. We investigated clinical …

Systemic glucocorticoid therapy is used worldwide by one to three percent of the general
population and 0.5-1.8% on long-term oral glucocorticoid use. It is widely used in conditions …

Glucocorticoid-induced adrenal insufficiency is caused by exogenous glucocorticoid
suppression of the hypothalamic-pituitary-adrenal axis and is the most prevalent form of …

Objective This study aims to identify susceptibility markers for adrenal crises (AC) in
educated patients with chronic adrenal insufficiency (AI). Design A case–control study …

Adrenal insufficiency is characterised by inadequate glucocorticoid production owing to
destruction of the adrenal cortex or lack of adrenocorticotropic hormone stimulation. In …